Meta Leads Big Tech Lobbying Expenditures as Artificial Intelligence Labs Push for Antitrust Exemptions
Major artificial intelligence laboratories have turned their attention to Capitol Hill to navigate complex antitrust regulations, pressing lawmakers for carve-outs that would permit information-sharing on security risks without running afoul of federal competition rules. Federal lobbying disclosures filed for the third quarter reveal that firms such as Anthropic and OpenAI engaged federal officials on the legal boundaries governing inter-company cooperation.
Anthropic explicitly targeted specific legislation in its lobbying efforts, with disclosures pointing to the Collaboration on Adversarial Threats and Security Risks Act. This proposed bill is designed to allow competing artificial intelligence laboratories to coordinate and share data regarding security threats without triggering antitrust penalties. Observers indicate that the legislation could potentially secure passage as an attachment to critical, must-pass defense policy legislation.
Meanwhile, OpenAI utilized broader language in its disclosure filings, noting discussions centered on artificial intelligence security collaboration and information-sharing, accompanied by proposed antitrust protections. Federal lobbying forms do not specify whether the participating companies advocated in favor of or in opposition to the specific policy proposals discussed during meetings with congressional offices.
The push for antitrust considerations follows recent discussions among industry leaders concerning a coordinated slowdown in artificial intelligence development. These companies maintain a regular presence in Washington, frequently lobbying federal lawmakers on proposed regulatory frameworks governing artificial intelligence, alongside related legislation targeting export controls and massive data center infrastructure.
The debate over regulatory relief has drawn mixed reactions from political figures and industry representatives. Chris Lehane, head of global affairs at OpenAI, has publicly contended that an explicit antitrust exemption specifically tailored for model pacing is unnecessary. However, incoming administration officials have pushed back against artificial intelligence executives requesting such legal carve-outs, arguing that firms possess the independent capacity to decide to slow down their development timelines without requiring formal government intervention or blessing.
